Aspenwood Capital partner Steve Ossello said, "The Aspenwood partners have always been tremendous supporters of the company and its primary product - Protandim®. The science behind Protandim is incredible and given the recent quality additions to the board and the significant growth LifeVantage is experiencing, we're very excited about its potential."
LifeVantage CEO and President David Brown said, "We are extremely pleased with Aspenwood's continued support. The quality of both the institutional and individual investors that they have brought to our company is truly remarkable. We're confirming that this raise provides the company with the capital it needs to get through profitability."
